Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences RNAi & miRNA

Scott Eliasof's Biography



Scott Eliasof, Vice President, Cerulean Pharma Inc

Sorry, There is currently no biography for this presenter.

Scott Eliasof Image

Systemic Delivery of a Tumor-Targeted Polymeric Nanoparticle Achieves Durable RNAi-Mediated Silencing in Breast Orthotopic Xenograft

Friday, 20 April 2012 at 16:15

Add to Calendar ▼2012-04-20 16:15:002012-04-20 17:15:00Europe/LondonSystemic Delivery of a Tumor-Targeted Polymeric Nanoparticle Achieves Durable RNAi-Mediated Silencing in Breast Orthotopic XenograftSELECTBIOenquiries@selectbiosciences.com

We will present durable in vivo RNAi silencing in an orthotopic breast xenograft model with minimal toxicity, using a novel nucleic acid carrier designed and developed with our tumor-targeted polymeric nanoparticle technology.


Add to Calendar ▼2012-04-19 00:00:002012-04-20 00:00:00Europe/LondonRNAi and miRNASELECTBIOenquiries@selectbiosciences.com